Crossmark

Immunotherapy-associated hemostatic abnormalities: bleeding and thrombotic complications

Published Online: 2025-07-01

Published Print: 2025-07

Authors

Li, Yingying

Jiang, Huiwen

Luo, Lili

Mei, Heng
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (82200144, 82100143)

National Key Research and Development Program of China (2023YFC2507805)

Wuhan Special Program for Knowledge Innovation (2023020201010054)
License Information

Text and Data Mining valid from 2025-07-01

Version of Record valid from 2025-07-01
More Information

Article History

Received: 11 March 2025

Accepted: 19 June 2025

First Online: 1 July 2025

Declarations

:

: The authors declare no competing interests.

Document is current